MAGNESIUM SULFATE INJECTION 50% USP
MAGNESIUM SULFATE INJECTION 50% USP
Discontinued
DIN Number
00602264
Drug Class
Human
Market Date
Dec 31, 1984
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00602264
AIG Number0105356002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05XA05 MAGNESIUM SULPHATE
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
,
Intramuscular
AHFS Classification40:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
MAGNESIUM SULFATEActive
Strength: 500 MG / ML
Monograph: MAGNESIUM SULFATE